Home | Recruitment

Recruiting

Trials by recruitment status

Public Title Date of registration Sponsor
Nimotuzumab inoperable esophageal epithelial tumors, Phase IV 30/06/2016 CIM
Treatment for maxillary cysts 30/05/2018 SSA
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extension 29/09/2017 CENSA
Predictor of response with CIMAvax EGF© in NSCLC Phase III 29/01/2016 CIM
Racotumomab,Nimotuzumab or Docetaxel in the treatment of the advanced non-small cell lung cancer. 26/05/2014 CIM
SURFACEN in ARDS. Adults. Phase IV 24/06/2015 CENSA
Itolizumab (T1h) combined with insulin in patients with Type I Diabetes Mellitus 23/12/2016 CIM
Phase II / III. Nimotuzumab in patients with triple-negative breast cancer. 23/05/2014 CIM
DENIS Study 22/10/2018 CIGB
Interferon Combination in basal cell carcinoma (InCarbacel-IV study) 22/08/2013 CIGB
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II 22/04/2016 CIM
Totally Laparoscopic Hysterectomy with Single-Port Access. Validation of a new technique in Cuba. 22/04/2014 CNCMA
Pneumococcal conjugate vaccination among Warao children 2013-06-14 SAIB
Pharmacokinetics of the Intralesional administration of rhEGF (doses: 75 µg and 225 µg) in advance Diabetic Foot Ulcers 2013-02-08 CIGB
Nimotuzumab in tumors of head and neck .Phase IV 2013-02-01 CIMAB
Sublingual immunotherapy with VALERGEN-Asthma-Children-Phase II 2012-04-02 BIOCEN
Therapeutic clinical evaluation of the Plectranthus amboinicus Lour Spreng (Oregano French) tablets in patient with common cold 2011-11-22 CIDEM
Effectiveness and safety of ior®EPOCIM in Chronic Kidney Disease patients in pre-dialysis. 2011-11-11 CIMAB
MAGINC Study 2011-07-12 CIGB
HeberproGen Study 2011-05-20 CIGB